Subscribe to
our newsletters

Subscribe to our newsletters!

Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.

Search in Nordic Life Science Insight

-
March 2, 2018
Redoxis

NEW – In vivo models of Psoriasis and Psoriatic arthritis

Redoxis is now proud to offer models of Psoriasis (IMQ model) and Psoriatic Arthritis (MiP) model.

NEW – In vivo models of Psoriasis and Psoriatic arthritis

Redoxis is now proud to offer models of Psoriasis (IMQ model) and Psoriatic Arthritis (MiP) model.

-
Redoxis
-
March 2, 2018

Redoxis is now proud to offer models of Psoriasis (IMQ model) and Psoriatic Arthritis (MiP) model. Psoriasis is a common autoimmune disease affecting the skin but up to a third of the patients also have involvement of other organs such as joints resulting in psoriatic arthritis. For more information on our models for these diseases please visit this page.

Last updated:
March 2, 2018

Redoxis

Redoxis performs tailor-made preclinical studies combining dedication, experience and agility to provide reliable results to your project.

Click here to read more about us!
Get in touch with us!
Visit us
Send us mail

Redoxis is now proud to offer models of Psoriasis (IMQ model) and Psoriatic Arthritis (MiP) model. Psoriasis is a common autoimmune disease affecting the skin but up to a third of the patients also have involvement of other organs such as joints resulting in psoriatic arthritis. For more information on our models for these diseases please visit this page.

Last updated:
March 2, 2018

Redoxis

Redoxis performs tailor-made preclinical studies combining dedication, experience and agility to provide reliable results to your project.

Click here to read more about us!
Get in touch with us!
Visit us
Send us mail